当前位置:首页 - 行情中心 - 大禹生物(920970) - 财务分析 - 现金流量表

大禹生物

(920970)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金64,977,008.2231,965,789.2136,403,269.69101,933,343.73
  收到其他与经营活动有关的现金15,140,572.8814,181,094.492,874,417.741,602,474.38
  经营活动现金流入小计80,117,581.146,146,883.69139,277,687.43103,535,818.11
  购买商品、接受劳务支付的现金52,519,285.421,194,962.8572,817,016.8651,856,712.5
  支付给职工以及为职工支付的现金15,404,968.38,138,679.3830,612,264.6423,530,969.11
  支付的各项税费3,186,701.611,640,524.326,520,484.184,211,590.7
  支付其他与经营活动有关的现金5,376,273.262,560,287.8210,934,427.89,874,118.98
  经营活动现金流出小计76,487,228.5733,534,454.37120,884,193.4889,473,391.29
  经营活动产生的现金流量净额3,630,352.5312,612,429.3218,393,493.9514,062,426.82
二、投资活动产生的现金流量:
  收回投资收到的现金-8,020---
  收到的其他与投资活动有关的现金276,554.82---
  投资活动现金流入的平衡项目0---
  投资活动现金流入小计268,534.82---
  购建固定资产、无形资产和其他长期资产支付的现金10,566,307.663,788,458.868,133,418.26,886,536.2
  投资支付的现金196.72---
  支付其他与投资活动有关的现金276,554.82120,000--
  投资活动现金流出小计10,843,059.23,908,458.868,133,418.26,886,536.2
  投资活动产生的现金流量净额-10,574,524.38-3,908,458.86-8,133,418.2-6,886,536.2
三、筹资活动产生的现金流量:
  取得借款收到的现金58,400,00021,000,00082,600,00065,000,000
  筹资活动现金流入小计58,400,00021,000,00082,600,00065,000,000
  偿还债务支付的现金29,400,0001,900,00084,600,00070,300,000
  分配股利、利润或偿付利息支付的现金1,317,914.47584,659.452,386,142.311,827,260.05
  支付其他与筹资活动有关的现金587,890.8304,242--
  筹资活动现金流出小计31,305,805.272,788,901.4586,986,142.3172,127,260.05
  筹资活动产生的现金流量净额27,094,194.7318,211,098.55-4,386,142.31-7,127,260.05
五、现金及现金等价物净增加额20,150,022.8826,915,069.015,873,933.4448,630.57
  加:期初现金及现金等价物余额25,674,833.7425,674,833.7419,800,900.319,800,900.3
  期末现金及现金等价物余额45,824,856.6252,589,902.7525,674,833.7419,849,530.87
补充资料:
  净利润-9,022,787.72--23,942,694.68-
  资产减值准备664,313.34-3,608,656.5-
  固定资产和投资性房地产折旧13,817,864.73-24,859,431.24-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,817,864.73-24,859,431.24-
  无形资产摊销595,070.82-1,493,591.41-
  长期待摊费用摊销--25,091.44-
  固定资产报废损失--64,326.12-
  财务费用1,376,682.4-2,391,334.78-
  投资损失-20,383.28---
  递延所得税--624,731.44-
  其中:递延所得税资产减少--624,731.44-
  存货的减少-15,565,911.81-8,033,389.17-
  经营性应收项目的减少6,287,480.6-2,584,157.45-
  经营性应付项目的增加4,507,466.28--4,746,783.66-
  现金的期末余额45,824,856.62-25,674,833.74-
  减:现金的期初余额25,674,833.74-19,800,900.3-
  现金及现金等价物的净增加额20,150,022.88-5,873,933.44-
公告日期2025-08-252025-04-282025-04-282024-10-28
审计意见(境内)标准无保留意见
TOP↑